Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DX25F6AFH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $328,166
Award facts
- Contract value 100% obligated
- $328,166.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $328,166 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The delivery order is for Keytruda (pembrolizumab) 100 mg/4 mL vials, an oncology therapeutic used in cancer treatment, with an ultimate completion date of September 29, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. The IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. As a key supplier in the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group maintains a robust portfolio of contract awards covering branded and generic prescription drugs, biologics, and medical consumables distributed to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AFH?
SPE2DX25F6AFH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 8, 2025.
How much is contract SPE2DX25F6AFH worth?
The government has obligated $328,166 on SPE2DX25F6AFH.
Is contract SPE2DX25F6AFH an order under another contract?
Yes. SPE2DX25F6AFH is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFH competed?
The extent of competition for SPE2DX25F6AFH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award